Home > News > Phoenix firm to provide $40M in VC funds
June 20th, 2005
Phoenix firm to provide $40M in VC funds
A new Phoenix bioscience firm that provides scientific expertise to venture capital funds is in the process of forming its own $40 million pool to help industry startups get their products to market.
Scientists who give their input on technology, such as proteomics and nano-biotechnologies, also would have the opportunity to participate in the VC fund they are helping, said Neff, who serves as chief executive of Bioscience Intelligence Advisors.
Bioscience Intelligence Advisors
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014
Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014